We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00159549
First Posted: September 12, 2005
Last Update Posted: January 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Central Norway Regional Health Authority
Information provided by:
Norwegian University of Science and Technology
  Purpose
A parallell group study comparing the effect of an education program with an education and training program for patients with COPD. 30 participants in each group. Participants self-select which group they wanted to be in. Main outcome is SGRQ (a HQoL for patients with COPD).

Condition Intervention
Chronic Obstructive Pulmonary Disease Behavioral: education and training program

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • St Geoprg Respiratory Questionnaire (SGRQ)

Secondary Outcome Measures:
  • COPD-Efficacy scale (Norwegian short version), Breathing Problems Questionnaire (BPQ), journal examinations, FVC, FEV1, six minutes walking test with registration of shortness of breath and pulseoxymetrical data.

Enrollment: 60
Study Start Date: January 2000
Estimated Study Completion Date: December 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients diagnosed with COPD (FEV1<75% of expected) who have the ability to conversation and active participation will be included.

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00159549


Locations
Norway
Department of Community Medicine and General Practice
Trondheim, Norway, N-7489
Sponsors and Collaborators
Norwegian University of Science and Technology
Central Norway Regional Health Authority
Investigators
Principal Investigator: Aslak Steinsbekk, PhD Norwegian University of Science and Technology
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00159549     History of Changes
Other Study ID Numbers: DMF 05/414
First Submitted: September 8, 2005
First Posted: September 12, 2005
Last Update Posted: January 18, 2017
Last Verified: January 2017

Keywords provided by Norwegian University of Science and Technology:
Patient education

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases